APA (7th ed.) Citation

DA, E., DM, S., X, W., I, V., H, D. S., C, S., . . . R, J. (2026). Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL. Oncology and therapy. https://doi.org/10.1007/s40487-026-00452-9

Chicago Style (17th ed.) Citation

DA, Ermann, et al. "Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL." Oncology and Therapy 2026. https://doi.org/10.1007/s40487-026-00452-9.

MLA (9th ed.) Citation

DA, Ermann, et al. "Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL." Oncology and Therapy, 2026, https://doi.org/10.1007/s40487-026-00452-9.